1657125318.678681065s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +9Ph3vsCT0sjfQEmRsOFqxklNNq6LGTFL#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-prf_acq-clinical_run-01_channels.tsv
1657125321.057563972s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +GtT8vcwtgPTBAxpmFiWwTsVs448Xl0Hy#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-prf_acq-clinical_run-02_channels.tsv
1657125323.485579495s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +7U5m5Rxn4gT0daleJcWaKHOyxGvBXudT#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-prf_acq-clinical_run-03_channels.tsv
1657125325.945217596s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +yTd7uI72IOEpbpfYTP_Pvj1ZXj0V0JmK#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-prf_acq-clinical_run-04_channels.tsv
1657125328.47015688s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +ze_IVFWnFsGJwYwU30ibLbu7uMbGDieu#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-soc_acq-clinical_run-01_channels.tsv
1657125330.726798876s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +4TZLmfPs3QUEZevKm0kyAgHJly4SsWPQ#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-soc_acq-clinical_run-02_channels.tsv
1657125334.053874776s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +ZitgVcsL9NDNegVniR6k6YCQtoXMZASq#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-soc_acq-clinical_run-03_channels.tsv
1657125336.939398995s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +gPfPaRM72IUJcdtrabCMfuQiuEL_lmLT#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-soc_acq-clinical_run-04_channels.tsv
1657125339.821107432s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +SSzC8jvq2Vk31wJjmU8MTJsddOERkTei#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-soc_acq-clinical_run-05_channels.tsv
1657125342.603549088s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +0xcWGxKf1HcylyEaLwuYqB4KHU7YEqlW#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-soc_acq-clinical_run-06_channels.tsv
1657125345.402288855s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +3yYP.f5nw2c_SPHejjoWy0Cc5oTRlBcj#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-soc_acq-clinical_run-07_channels.tsv
1657125348.290924627s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +Wy9Q54nFtd9Xs1aIK0lIzmQJD4.D6LFP#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-soc_acq-clinical_run-08_channels.tsv
1657125351.145146183s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +mG0mX0elqTw9XImP6cV0_eHL3Q8yc6YT#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-soc_acq-clinical_run-09_channels.tsv
1657125354.042660966s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +7yxInUiJXuU_5nFzHZc9yAfFD_4SmDCf#ds004194/sub-p04/ses-nyuecog01/ieeg/sub-p04_ses-nyuecog01_task-soc_acq-clinical_run-10_channels.tsv
